Nuclear Medicine Program progress report for quarter ending September 30, 1989
In this report, an evaluation of the effects of albumin and albumin plus sodium palmitate in the phosphate buffer perfusate on the relative of unmetabolized fatty acid and the unknown metabolite(s) from isolated rat hearts administered 15-(p-(I-125)iodophenyl)-3-(R, S)-methylpentadecanoic acid (BMIPP) is described. Earlier studies had demonstrated the presence of a major unidentified polar radioactive component in the outflow of hearts injected with BMIPP and perfused with the traditional Krebs-Henseleit (KH) buffer, which does not contain albumin. The current studies were performed with KH buffer containing either albumin (BSA) or albumin and palmitate (BSA/PAL) to assess the relative loss of the metabolite and unmetabolized BMIPP from the perfused hearts. The results demonstrated that in the presence of albumin both the unidentified material and BMIPP are present in the outflow (i.e., 5 min perfusate buffer, % BMIPP: KH, 3%; KH + BSA, 10%; KH + BSA/PAL, 41%). These results demonstrate that BMIPP is a major radioactive component in the outflow of isolated hearts using a perfusate containing BSA and palmitate and, more importantly, suggest for the first time that the slow myocardial wash-out observed in humans after administration of (I-123)BMIPP probably represents loss of both unmetabolized BMIPP and the unidentified metabolite. Coronary sinus sampling studies with dogs are now in progress to relate the relative contribution of these two components to the release of radioactivity from the heart. Also in this report, our population experience for several radioisotopes being used by the ORNL Nuclear Medicine Program is summarized.
- Research Organization:
- Oak Ridge National Lab., TN (USA)
- Sponsoring Organization:
- DOE/ER
- DOE Contract Number:
- AC05-84OR21400
- OSTI ID:
- 5358657
- Report Number(s):
- ORNL/TM-11377; ON: DE90004434
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nuclear Medicine Program progress report for quarter ending March 31, 1990
Nuclear Medicine Program progress report for quarter ending September 30, 1988
Radioiodinated methyl-branched fatty acids: Evaluation of catabolites formed in vivo
Technical Report
·
Sun Jul 01 00:00:00 EDT 1990
·
OSTI ID:7015943
Nuclear Medicine Program progress report for quarter ending September 30, 1988
Technical Report
·
Tue Feb 28 23:00:00 EST 1989
·
OSTI ID:6151410
Radioiodinated methyl-branched fatty acids: Evaluation of catabolites formed in vivo
Conference
·
Wed Dec 31 23:00:00 EST 1986
·
OSTI ID:7163868
Related Subjects
550500 -- Metabolism
550600* -- Medicine
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
BODY
CARBOXYLIC ACIDS
CARDIOVASCULAR SYSTEM
CHEMICAL REACTIONS
CHEMISTRY
DOCUMENT TYPES
DRUGS
HALOGENATION
HEART
IODINATION
LABELLED COMPOUNDS
MAMMALS
MEDICINE
MONOCARBOXYLIC ACIDS
NUCLEAR MEDICINE
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANS
PROGRESS REPORT
PURIFICATION
RADIOCHEMISTRY
RADIOPHARMACEUTICALS
RATS
RODENTS
SALES
SYNTHESIS
VERTEBRATES
550600* -- Medicine
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
BODY
CARBOXYLIC ACIDS
CARDIOVASCULAR SYSTEM
CHEMICAL REACTIONS
CHEMISTRY
DOCUMENT TYPES
DRUGS
HALOGENATION
HEART
IODINATION
LABELLED COMPOUNDS
MAMMALS
MEDICINE
MONOCARBOXYLIC ACIDS
NUCLEAR MEDICINE
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANS
PROGRESS REPORT
PURIFICATION
RADIOCHEMISTRY
RADIOPHARMACEUTICALS
RATS
RODENTS
SALES
SYNTHESIS
VERTEBRATES